Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tyenne 162mg/0.9ml solution for injection pre-filled pens
1001030W0BCABAE
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 200mg/10ml concentrate for inf vials
1001030W0BCADAB
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 400mg/20ml concentrate for inf vials
1001030W0BCACAC
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tyenne 80mg/4ml concentrate for solution for infusion vials
1001030W0BCAEAA
|
Tyenne | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
|
Tygacil 50mg powder for solution for infusion vials
0501030Y0BBAAAA
|
Tygacil | Tigecycline | Infections | No data available |
|
Tylex 30mg/500mg effervescent tablets
0407010F0BEABAF
|
Tylex | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Tyloxapol 0.125% solution
0307000P0AAAAAA
|
Tyloxapol | Tyloxapol | Respiratory System | No data available |
|
Typherix 25micrograms/0.5ml vacc inj pre-filled syringes
1404000S0BFAAAD
|
Typherix | Typhoid | Immunological Products and Vaccines | No data available |
|
TYR Anamix Infant methionine free powder
0913701A0BBAAAA
|
TYR powder infant formula | Powder infant formula (0913701) | Nutrition and Blood | No data available |
|
TYR Anamix Junior oral powder 29g sachets
0913227B0BBACAC
|
TYR powder 10g protein equivalent | Powder 10g protein equivalent (0913227) | Nutrition and Blood | No data available |
|
TYR Easy Shake & Go oral powder 34g sachets
0913206A0BBABAB
|
TYR powder 15g protein equivalent | Powder 15g protein equivalent (0913206) | Nutrition and Blood | No data available |
|
TYR gel oral powder 20g sachets
090401000BBLRA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
TYR Maxamaid powder
090401000BBDQA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
Tyrosine 500mg capsules
091101000AAFEFE
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Tyrosine powder
0913213A0AAAGAG
|
Powder single L-amino acid supplement (0913213) | Powder single L-amino acid supplement (0913213) | Nutrition and Blood | No data available |
|
Tyruko 300mg/15ml concentrate for inf vials
0802040W0BCAAAA
|
Tyruko | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tysabri 300mg/15ml concentrate for inf vials
0802040W0BBAAAA
|
Tysabri | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tyvera 100mg tablets (Almus)
0906026M0BGADAG
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyvera 100mg tablets (Auden McKenzie)
0906026M0BGABAG
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyvera 100mg tablets (Teva)
0906026M0BGAFAG
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyvera 50mg tablets (Almus)
0906026M0BGACAF
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyvera 50mg tablets (Auden McKenzie)
0906026M0BGAAAF
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyvera 50mg tablets (Teva)
0906026M0BGAEAF
|
Tyvera | Thiamine hydrochloride | Nutrition and Blood | No data available |
|
Tyverb 250mg tablets
0801050ATBBAAAA
|
Tyverb | Lapatinib | Malignant Disease and Immunosuppression | No data available |
|
U-drain consumable pack tapered ridge connector
22806208002
|
U-drain consumable pack tapered ridge connector | Tubing And Accessories | Incontinence Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.